XML 12 R2.htm IDEA: XBRL DOCUMENT v3.22.2
Consolidated Statements of Income - USD ($)
shares in Thousands, $ in Millions
 3 Months Ended 9 Months Ended
Jun. 25, 2022
Jun. 26, 2021
Jun. 25, 2022
Jun. 26, 2021
Revenues:        
Product $ 837.1 $ 995.2 $ 3,408.7 $ 3,829.4
Service and other 165.6 173.1 500.9 486.3
Revenues 1,002.7 1,168.3 3,909.6 4,315.7
Costs of revenues:        
Product 266.3 303.9 907.0 889.1
Amortization, Cost of Goods Sold 75.9 68.1 223.1 194.2
Impairment of acquired intangible assets 9.2 0.0 9.2 0.0
Service and other 101.5 94.7 287.6 264.7
Gross profit 549.8 701.6 2,482.7 2,967.7
Operating expenses:        
Research and development 65.1 69.0 207.4 199.8
Selling and marketing 152.3 142.7 471.0 402.2
General and administrative 91.9 117.3 310.5 297.7
Amortization of acquired intangible assets 11.2 10.4 33.2 30.7
Contingent consideration - fair value adjustments (35.4) 0.0 (39.5) (10.1)
Restructuring and divestiture charges 0.8 3.6 0.8 6.6
Operating expenses 285.9 343.0 983.4 926.9
Income from operations 263.9 358.6 1,499.3 2,040.8
Interest income 2.4 0.4 3.6 1.1
Interest expense (22.7) (21.6) (71.0) (70.9)
Debt extinguishment loss 0.0 0.0 (0.7) (21.6)
Other income, net 4.8 0.1 13.6 1.1
Income before income taxes 248.4 337.5 1,444.8 1,950.5
Provision for income taxes 20.0 69.4 261.5 409.6
Net income 228.4 268.1 1,183.3 1,540.9
Net loss attributable to noncontrolling interest 0.0 (0.3) 0.0 (1.8)
Net income attributable to Hologic $ 228.4 $ 268.4 $ 1,183.3 $ 1,542.7
Net income per common share attributable to Hologic:        
Basic (in usd per share) $ 0.91 $ 1.05 $ 4.70 $ 5.98
Diluted (in usd per share) $ 0.90 $ 1.04 $ 4.65 $ 5.93
Weighted average number of shares outstanding:        
Basic (in shares) 250,756 256,230 251,943 257,769
Diluted (in shares) 253,093 258,581 254,273 260,371